Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogens.

Derby NR, Gray S, Wayner E, Campogan D, Vlahogiannis G, Kraft Z, Barnett SW, Srivastava IK, Stamatatos L.

Virology. 2007 Sep 30;366(2):433-45. Epub 2007 Jun 8.

PMID:
17560621
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection.

Derby NR, Kraft Z, Kan E, Crooks ET, Barnett SW, Srivastava IK, Binley JM, Stamatatos L.

J Virol. 2006 Sep;80(17):8745-62. Erratum in: J Virol. 2007 Feb;81(3):1538.

PMID:
16912322
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Characterization of neutralizing antibody responses elicited by clade A envelope immunogens derived from early transmitted viruses.

Kraft Z, Strouss K, Sutton WF, Cleveland B, Tso FY, Polacino P, Overbaugh J, Hu SL, Stamatatos L.

J Virol. 2008 Jun;82(12):5912-21. doi: 10.1128/JVI.00389-08. Epub 2008 Apr 9.

PMID:
18400850
[PubMed - indexed for MEDLINE]
Free PMC Article
4.
5.

Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.

Richardson TM Jr, Stryjewski BL, Broder CC, Hoxie JA, Mascola JR, Earl PL, Doms RW.

J Virol. 1996 Feb;70(2):753-62.

PMID:
8551612
[PubMed - indexed for MEDLINE]
Free PMC Article
7.
8.

Alterations in the immunogenic properties of soluble trimeric human immunodeficiency virus type 1 envelope proteins induced by deletion or heterologous substitutions of the V1 loop.

Ching L, Stamatatos L.

J Virol. 2010 Oct;84(19):9932-46. doi: 10.1128/JVI.00868-10. Epub 2010 Jul 21.

PMID:
20660181
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Changes in the immunogenic properties of soluble gp140 human immunodeficiency virus envelope constructs upon partial deletion of the second hypervariable region.

Srivastava IK, VanDorsten K, Vojtech L, Barnett SW, Stamatatos L.

J Virol. 2003 Feb;77(4):2310-20.

PMID:
12551968
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies.

Choudhry V, Zhang MY, Sidorov IA, Louis JM, Harris I, Dimitrov AS, Bouma P, Cham F, Choudhary A, Rybak SM, Fouts T, Montefiori DC, Broder CC, Quinnan GV Jr, Dimitrov DS.

Virology. 2007 Jun 20;363(1):79-90. Epub 2007 Feb 15. Erratum in: Virology. 2007 Nov 25;368(2):431.

PMID:
17306322
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate.

Srivastava IK, Stamatatos L, Kan E, Vajdy M, Lian Y, Hilt S, Martin L, Vita C, Zhu P, Roux KH, Vojtech L, C Montefiori D, Donnelly J, Ulmer JB, Barnett SW.

J Virol. 2003 Oct;77(20):11244-59.

PMID:
14512572
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptible primary HIV type 1 isolates.

Stamatatos L, Lim M, Cheng-Mayer C.

AIDS Res Hum Retroviruses. 2000 Jul 1;16(10):981-94.

PMID:
10890360
[PubMed - indexed for MEDLINE]
13.

Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein.

Edinger AL, Ahuja M, Sung T, Baxter KC, Haggarty B, Doms RW, Hoxie JA.

J Virol. 2000 Sep;74(17):7922-35.

PMID:
10933700
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The C108g epitope in the V2 domain of gp120 functions as a potent neutralization target when introduced into envelope proteins derived from human immunodeficiency virus type 1 primary isolates.

Pinter A, Honnen WJ, D'Agostino P, Gorny MK, Zolla-Pazner S, Kayman SC.

J Virol. 2005 Jun;79(11):6909-17.

PMID:
15890930
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities.

Earl PL, Broder CC, Long D, Lee SA, Peterson J, Chakrabarti S, Doms RW, Moss B.

J Virol. 1994 May;68(5):3015-26.

PMID:
7512157
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120.

Beddows S, Franti M, Dey AK, Kirschner M, Iyer SP, Fisch DC, Ketas T, Yuste E, Desrosiers RC, Klasse PJ, Maddon PJ, Olson WC, Moore JP.

Virology. 2007 Apr 10;360(2):329-40. Epub 2006 Nov 28.

PMID:
17126869
[PubMed - indexed for MEDLINE]
Free Article
18.

The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region.

Barnett SW, Lu S, Srivastava I, Cherpelis S, Gettie A, Blanchard J, Wang S, Mboudjeka I, Leung L, Lian Y, Fong A, Buckner C, Ly A, Hilt S, Ulmer J, Wild CT, Mascola JR, Stamatatos L.

J Virol. 2001 Jun;75(12):5526-40.

PMID:
11356960
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies.

Kim M, Qiao ZS, Montefiori DC, Haynes BF, Reinherz EL, Liao HX.

AIDS Res Hum Retroviruses. 2005 Jan;21(1):58-67.

PMID:
15665645
[PubMed - indexed for MEDLINE]
20.

Engineering, expression, purification, and characterization of stable clade A/B recombinant soluble heterotrimeric gp140 proteins.

Sellhorn G, Kraft Z, Caldwell Z, Ellingson K, Mineart C, Seaman MS, Montefiori DC, Lagerquist E, Stamatatos L.

J Virol. 2012 Jan;86(1):128-42. doi: 10.1128/JVI.06363-11. Epub 2011 Oct 26.

PMID:
22031951
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk